Show simple item record

AuthorIsaifan, Dina
AuthorCrovella, Sergio
AuthorSoubra, Lama
Available date2022-12-20T09:58:28Z
Publication Date2022-11-11
Publication NameToxicology and Applied Pharmacology
Identifierhttp://dx.doi.org/10.1016/j.taap.2022.116293
CitationDina Isaifan, Toxicology and Applied Pharmacology, https://doi.org/10.1016/j.taap.2022.116293
ISSN0041008X
URIhttps://www.sciencedirect.com/science/article/pii/S0041008X22004380
URIhttp://hdl.handle.net/10576/37425
AbstractIn reference to the article (SARS-CoV-2 in Atmospheric Particulate Matter: An Experimental Survey in the Province of Venice in Northern Italy) published in the Journal of Environmental Research and Public Health in August 2022, we thank the authors (Pivato et al., 2022) for their valuable work and we would like to share our point of view on the article. Regarding the evidenced link connecting the levels of atmospheric particulate matter (PM) with SARS-CoV-2 prevalence, we would like to seize this opportunity to highlight the impact of (PM) on speeding the COVID-19 incidence from a closer perspective by focusing on the non-coding RNAs (ncRNAs) such as small interfering RNAs (siRNAs) and how this may enhance the viral activity of SARS-CoV-2.
Languageen
PublisherElsevier
SubjectInflammation
environmental pulmonary health
TitleInflammation resolution in environmental pulmonary health and morbidity
TypeArticle
dc.accessType Full Text


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record